Volume 13, Issue 4 (5-2015)                   IJRM 2015, 13(4): 227-230 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zadehmodarres S, Heidar Z, Razzaghi Z, Ebrahimi L, Soltanzadeh K, Abed F. Anti-mullerian hormon level and polycystic ovarian syndrome diagnosis. IJRM. 2015; 13 (4) :227-230
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-637-en.html
1- Infertility and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- Infertility and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran , dr_zheidar@yahoo.com
3- Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4- Infertility Ward, Mahdieh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract:   (508 Views)
Background: Polycystic ovarian syndrome (PCOS) is a common endocrinopathy that accompanied with long term complications. The early diagnosis of this syndrome can prevent it.
Objective: The aim was to determine the role of anti-mullerian hormon (AMH) in PCOS diagnosis and to find cut off level of it.
Materials and Methods: In this cross sectional study, 117 women between 20-40 years old were participated in two groups: 60 PCOS women (based on Rotterdam criteria consensus) as the case group and 57 normal ovulatory women as the control group. In day 2-4 of cycle, transvaginal sonography was performed and serum hormonal level of AMH, luteinizing hormone (LH), follicle stimulating hormone (FSH), estradiol (E 2 ), testosterone, fasting blood sugar (FBS), thyroid stimulating hormone (TSH), and prolactin (PRL) were measured in all of participants. For all of them score of hirsutism (base on Freeman-Galloway scoring) was determined.
Results: There were statistically significant in irregular pattern of menstruation, AMH and FSH level, and presence of hirsutism between two groups. But regarding mean of age, body mass index, plasma level of PRL, TSH, LH, Testosterone, FBS, and E 2 differences were not significant. Construction by ROC curve present 3.15 ng/ml as AMH cut off with 70.37% sensitivity and 77.36% specificity in order to PCOS diagnosis.
Conclusion: AMH with cut off level of 3.15 ng/ml with sensitivity 70.37% and specificity 77.36% could use for early diagnosis of PCOS patients.
Full-Text [PDF 398 kb]   (93 Downloads) |   |   Full-Text (HTML)  (67 Views)  
Type of Study: Original Article |

References
1. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007; 370: 685-697. [DOI:10.1016/S0140-6736(07)61345-2]
2. Welt CK, Gudmundsson JA, Arason G, Adams J, Palsdottir H, Gudlaugsdottir G, et al. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab 2006; 91: 4842-4848. [DOI:10.1210/jc.2006-1327]
3. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91: 4237-4245. [DOI:10.1210/jc.2006-0178]
4. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004; 10: 77-83. [DOI:10.1093/molehr/gah015]
5. Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, et al. Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003; 88: 5957-5962. [DOI:10.1210/jc.2003-030727]
6. Wild RA, Carmina E, Diamanti-Kandarakis E. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Exess and polycystic ovary syndrome Society. J Clin Endocrinol Metab 2010; 95: 2038. [DOI:10.1210/jc.2009-2724]
7. Eilertsen TB, Vanky E, Carlsen SM. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod 2012; 27: 2494-2502. [DOI:10.1093/humrep/des213]
8. Villarroel C, MerinoPM, Lo´pez P, Eyzaguirre FC. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone. Hum Reprod 2011; 26: 2861-2868. [DOI:10.1093/humrep/der223]
9. Chao KC, Ho CH, Shyong WY, Huang CY, Tsai SC, Cheng HY, et al. Anti mullerian hormone serum level as a predictive marker of ovarian function in Taiwanese women. J Chin Med Assoc 2012; 75: 70-74. [DOI:10.1016/j.jcma.2011.12.007]
10. Carmina E, Campagna AM, Mansuet P, Vitale G, Kort D, Lobo R. Dose the level of serum anti mullerian hormone predict ovulatory function in women with PCOS with aging. Fertil Steril 2012; 98: 1043-1046. [DOI:10.1016/j.fertnstert.2012.06.017]
11. Woo HY, Kim KH, Rhee EJ. Differeces of the association of anti-Mullerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome. Endocrine J 2012; 59: 781-790. [DOI:10.1507/endocrj.EJ12-0055]
12. Pingy P, Jonard S, Robert Y, Dewailly D. Serum anti- Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91: 941-944. [DOI:10.1210/jc.2005-2076]
13. Swellam M, Khaial A, Mosa T, El-Baz H. Anti-Mullerian and androgens hormones in women66 with polycystic ovary syndrome undergoing IVF/ICSI. Iran J Reprod Med 2013; 11: 883-890.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2020 All Rights Reserved | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb